Skip to main navigation
Investor Relations
Press ReleasesCompany StatementsMedia ContactEmail Alerts
Events & PresentationsFinancialsStock InformationGovernanceResources
Compliance & Transparency
Our LocationsMedical Information
magnifying glass icon
Incyte Home
Main Nav
  • Our Company
  • What We Do
  • Culture & Careers
  • Patient Resources
  • HCP Resources
  • Our Stories
  • Responsibility
  • Our Company
    • Our Leadership
  • What We Do
    • Portfolio
    • Hematology and Oncology
      • Approved Therapies
      • HCP Resources
    • Inflammation and Autoimmunity
      • Approved Therapies
      • HCP Resources
    • Partnerships
  • Culture & Careers
    • Open Positions
    • Incyte Involved
    • Inclusion
  • Patient Resources
  • HCP Resources
  • Our Stories
  • Responsibility
    • Compliance & Transparency
Main Nav
  • magnifying glass icon
  • Our Company
    • magnifying glass icon
    • Our Leadership
  • What We Do
    • magnifying glass icon
    • Portfolio
    • Hematology and Oncology
    • Inflammation and Autoimmunity
    • Partnerships
  • Culture & Careers
    • magnifying glass icon
    • Open Positions
    • Incyte Involved
    • Inclusion
  • Patient Resources
  • HCP Resources
  • Our Stories
  • News
    • magnifying glass icon
    • Company Statements
    • Media Contact
    • Email Alerts
  • Investors
    • magnifying glass icon
    • Events & Presentations
    • Financials
    • Stock Information
    • Governance
    • Resources
  • Responsibility
    • magnifying glass icon
    • Compliance & Transparency
  • Contact Us
    • magnifying glass icon
    • Our Locations
    • Medical Information
  • United States
Home  >  Investors

Investors

Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives.

Incyte International Locations

NORTH AMERICA— HEADQUARTERS

DENMARK

ITALY

SPAIN

UNITED KINGDOM

EUROPE— HEADQUARTERS

FINLAND

JAPAN

SWEDEN

AUSTRIA

FRANCE

THE NETHERLANDS

SWITZERLAND

CANADA

GERMANY

NORWAY

PORTUGAL

Close


Quick Links

  • Investor Presentation
  • Responsibility
  • News
  • Portfolio
  • Responsibility Report
  • Annual Reports
  • Leadership
  • Governance
  • SEC Filings

Latest Press Releases

April 29, 2026
Incyte to Present at Upcoming Investor Conferences
April 28, 2026
Incyte Reports First Quarter 2026 Financial Results and Provides Business Updates
April 28, 2026
Incyte Appoints Suketu (Suky) Upadhyay as Chief Financial Officer
All press releases

Latest Events

May 19 2026 May 19 2026
RBC Global Healthcare Conference
Click here for Webcast
May 13 2026 May 13 2026
BofA Securities Health Care Conference
Click here for Webcast
Apr 28 2026 Apr 28 2026
Q1 2026 Incyte Corporation Earnings Conference Call
Click here for Webcast
All events
Market Cap:
Volume:
Apr 12, 2026 12:53 AM EDT

Minimum 15 minutes delayed. Source: LSEG

Stock Info
Show all

Q1 2026 RESULTS

  • Press Release
  • Webcast
  • Presentation 1.5 MB
All Quarterly Results

Investor Relations Inquiries

IR@incyte.com

Incyte Home
  • LinkedIn Icon
  • Twitter Icon
  • Instagram Icon
  • Facebook Icon
  • Youtube Icon
  • Our Company
  • Our Leadership
  • What We Do
  • Portfolio
  • Hematology and Oncology
  • Inflammation and Autoimmunity
  • Partnerships
  • Culture & Careers
  • Open Positions
  • Incyte Involved
  • Inclusion
  • Patient Resources
  • HCP Resources
  • Our Stories
  • News
  • Press Releases
  • Company Statements
  • Media Contact
  • Email Alerts
  • Investors
  • Events & Presentations
  • Financials
  • Stock Information
  • Governance
  • Resources
  • Responsibility
  • Compliance & Transparency
  • Contact Us
  • Our Locations
  • Medical Information
  • Legal Notice
  • Suppliers
  • Site Map
  • Privacy Policy
  • Cookie Policy
  • Consumer Health Data Privacy Policy
© 2012-2026 Incyte.